Clincosm LogoSign in Get a demo

nonvalvular atrial fibrillation

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nonvalvular Atrial Fibrillation Trial in Beijing, Zhengzhou (E-SeaLA, CardioPulse PFA system)

Recruiting
  • Nonvalvular Atrial Fibrillation
  • E-SeaLA, CardioPulse PFA system
  • Beijing, Beijing, China
  • +1 more
Feb 7, 2023

Nonvalvular Atrial Fibrillation, Health, Subjective Trial in Beijing (Dabigatran etexilate capsule)

Recruiting
  • Nonvalvular Atrial Fibrillation
  • Health, Subjective
  • Dabigatran etexilate capsule
  • Beijing, China
    Peking University Third Hospital
Feb 6, 2023

Nonvalvular Atrial Fibrillation Trial in Paris

Recruiting
  • Nonvalvular Atrial Fibrillation
    • Paris, IIe-de-France, France
      Geriatric Department, Broca Hospital
    Jan 11, 2023

    Nonvalvular Atrial Fibrillation Trial in Angers (Rivaroxaban 20 MG, Warfarin)

    Recruiting
    • Nonvalvular Atrial Fibrillation
    • Angers, France
      Angers University Hospital
    Jul 25, 2022

    Japanese Patients With NonValvular Atrial Fibrillation

    Completed
    • NonValvular Atrial Fibrillation
    • Toyama-shi, Toyama, Japan
      Local Institution
    Jun 3, 2022

    Nonvalvular Atrial Fibrillation, Severe Degenerative Mitral Regurgitation Trial in Rochester, Ottawa (MitraClip TMVR and

    Recruiting
    • Nonvalvular Atrial Fibrillation
    • Severe Degenerative Mitral Regurgitation
    • MitraClip TMVR and Watchman LAAO
    • Rochester, Minnesota
    • +1 more
    Aug 5, 2021

    Oral Anticoagulant in Chinese Patients With NVAF

    Not yet recruiting
    • Nonvalvular Atrial Fibrillation
    • adherence
    • Hangzhou, Zhejiang, China
      Chang Cuie
    Jun 20, 2021

    Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

    Completed
    • Nonvalvular Atrial Fibrillation
    • Rivaroxaban (Xarelto, BAY59-7939)
    • Vitamin K antagonist (VKA)
    • Multiple Locations, Washington
      Truven Health MarketScan Commercial Claims and Medicare Suppleme
    Aug 13, 2020

    Eliquis Regulatory Post Marketing Surveillance

    Completed
    • NonValvular Atrial Fibrillation
    • Seoul, Korea, Republic of
      Local Institution
    Oct 27, 2017

    Hospital Readmissions Among Hospitalized Non-valvular Atrial

    Completed
    • Nonvalvular Atrial Fibrillation
      • (no location specified)
      Apr 6, 2016

      Nonvalvular Atrial Fibrillation Trial (AZD0837, Vitamin-K antagonist at INR 2-3)

      Completed
      Has Results
      • Nonvalvular Atrial Fibrillation
      • AZD0837
      • Vitamin-K antagonist at INR 2-3
      • (no location specified)
      Mar 20, 2012